MedPath

The Comparison of 32mm and 28mm Head Components in Alumina-alumina Total Hip Arthroplasty

Phase 4
Completed
Conditions
Arthroplasty, Replacement, Hip
Interventions
Device: 32mm ceramic head group
Device: 28mm ceramic head group
Registration Number
NCT01098604
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

It has been postulated that use of a larger femoral head could reduce the risk of dislocation after total hip arthroplasty, but only limited clinical data have been presented in third generation alumina bearings.

The purpose of this study is to evaluate the effect of femoral head size for total hip arthroplasty using third generation alumina bearings on the joint stability and clinical results.

The investigators hypothesized that larger ceramic head group has a similar rate of dislocation and clinical results in smaller ceramic head group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • osteonecrosis of femoral head
  • primary or secondary osteoarthritis of the hips
  • femoral neck fracture
Exclusion Criteria
  • previous hemi- or total hip arthroplasty
  • highly dislocated or severe ankylosed hip
  • patients who are considered potentially unreliable or who may not reliably attend study visits

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
32mm ceramic head group32mm ceramic head grouppatients performed with THA using 32mm ceramic head
28mm ceramic head group28mm ceramic head grouppatients performed with THA using 28mm ceramic head
Primary Outcome Measures
NameTimeMethod
rate of dislocation in each head size24 months

to evaluate the null hypothesis that the dislocation rate of larger ceramic head group is similar to smaller ceramic head group.

Secondary Outcome Measures
NameTimeMethod
clinical results using Harris Hip Score24 months

to compare the clinical results such as pain, function, range of motion between both groups.

Trial Locations

Locations (1)

Seoul national University Bundang Hospital

🇰🇷

Seongnam-Si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath